Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye

Japanese Journal of Ophthalmology

Volumn 48, Issue 4, 2004, Pages 321-327

  Matsuo, Toshihiko ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Dry eye syndrome; Eyedrop; Hyaluronan; Hydroxyethylcellulose; Trehalose

Indexed keywords

EYE DROPS; HYALEIN; HYALURONIC ACID; HYDROXYETHYLCELLULOSE; MYTEAR; ROSE BENGAL; TREHALOSE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EXTRACELLULAR FLUID; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSMOLARITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEAR FILM; VISCOSITY; WILCOXON SIGNED RANKS TEST;

EID: 3543040031     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-004-0085-8     Document Type: Article

References (19)

1. Schein OD, Munoz B, Tielsch JM, et al. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997;124:723-728.
2. McCarty CA, Bansal AK, Livingston PM, et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998;105: 1114-1119.
3. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-1268.
4. Sjögren H, Bloch KJ. Keratoconjunctivitis sicca and the Sjögren syndrome. Surv Ophthalmol 1971;16:145-159.
5. Fox RI, Robinson CA, Curd JG, et al. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-585.
6. Condon PI, McEwen CG, Wright M, Mackintosh G, Prescott RJ, McDonald C. Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome. Br J Ophthalmol 1999;83:1121-1124.
7. Crowe JH, Hoekstra FA, Crowe LM. Anhydrobiosis. Annu Rev Physiol 1992;54:579-599.
8. Crowe JH, Carpenter JF, Crowe LM. The role of vitrification in anhydrobiosis. Annu Rev Physiol 1998;60:73-103.
9. Guo N, Puhlev I, Brown DR, et al. Trehalose expression confers desiccation tolerance on human cells. Nat Biotechnol 2000;18: 168-171.
10. Matsuo T. Trehalose protects corneal epithelial cells from death by drying. Br J Ophthalmol 2001;85:610-612.
11. Matsuo T, Tsuchida Y, Morimoto N. Trehalose eyedrops in the treatment of dry eye syndrome. Ophthalmology 2002;109:2024-2029.
12. Lemp MA, Hamill JR. Factors affecting tear film breakup time in normal eyes. Arch Ophthalmol 1973;89:103-105.
13. van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969;82:10-14.
14. Bjerrum KB. Primary Sjögren's syndrome and keratoconjunctivitis sicca: diagnostic methods, frequency and social aspects. Acta Ophthalmol Scand Suppl 2000;231:1-37.
15. Lemp MA. Report of the National Eye Institute/industry workshop on clinical trials in dry eyes. CLAO J 1995;21:221-232.
16. Toda I, Fujishima H, Tsubota K. Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol Scand 1993;71:347-352.
17. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 1980;25:15-30.
18. Burstein NL. The effects of topical drugs and preservatives on the tear and corneal epithelium in dry eye. Trans Ophthalmol Soc UK 1985;104:402-409.
19. Wilson WS, Duncan AJ, Jay JL. Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 1975;59:667-669.